The Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa

Condition:   Retinitis Pigmentosa Interventions:   Drug: OCU400 Low Dose;   Drug: OCU400 Mid Dose;   Drug: OCU400 High Dose Sponsor:   Ocugen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials